(Bloomberg) -- Elon Musk’s reported drug use has Tesla Inc. board members facing a familiar quandary: having to decide what, if anything, to do about the chief executive subjecting directors and shareholders alike to great financial and legal risk.Most Read from BloombergMusk’s Drug Use Concerns Tesla, SpaceX Leaders, WSJ SaysBoeing Slumps After Panel Blowout Leads to Partial 737 GroundingChina Says It Caught Foreign Consultant Spying for UK’s MI6The Wall Street Journal’s article describing Musk...
Continue ReadingTencent's dominance extends beyond China, with its products and services being widely used internationally. Read more about TCEHY stock here...
Continue ReadingDiscover the latest developments in the global electric vehicle market, including record sales in the US, regulatory changes, and major company updates...
Continue ReadingI anticipate some further selling in Q1, but at a lower magnitude than previously expected. Click here for a detailed analysis...
Continue ReadingElon Musk’s lawyers have vehemently denied allegations of illegal drug use amid reports that Tesla and SpaceX executives are increasingly alarmed about his erratic behaviour...
Continue ReadingThe Wall Street Journal, on Saturday, published an article on alleged illegal drug use by Tesla CEO Elon Musk. Come Monday, investors will have to wrestle with what the news means for Tesla stock. Tesla didn’t respond to a request for comment...
Continue ReadingJeff Flock, a electric-vehicle newbie, chronicles the pros and cons of his trip from Chicago to New York City in a Tesla Model Y, a fully electric, mid-sized SUV...
Continue ReadingHere's everything you need to know about the electric vehicle maker's week...
Continue ReadingTesla's production surpassed 1.8 million units for 2023...
Continue ReadingThe ClearBridge Appreciation Strategy underperformed the benchmark S&P 500 Index in the fourth quarter of 2023. Click here to read the full fund letter...
Continue Reading© 2026 Market News — All rights reserved